These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Recall alerts in implantable cardioverter-defibrillator recipients: implications for patients and physicians. Schwartz J; Blangy H; Zinzius PY; Freysz L; Aliot E; Sadoul N Pacing Clin Electrophysiol; 2011 Jan; 34(1):96-103. PubMed ID: 21039641 [TBL] [Abstract][Full Text] [Related]
11. Should recent defibrillator and lead advisories affect decisions to refer patients for implantable cardioverter-defibrillator therapy? Amin MS; Ellenbogen KA Curr Opin Cardiol; 2010 Jan; 25(1):23-8. PubMed ID: 19907318 [TBL] [Abstract][Full Text] [Related]
12. [Postmarketing surveillance in patients with cardiac pace-makers or automatic implantable defibrillators]. Fauchier L; de Bouët du Portal H; Giraudeau C; Froger S; Cosnay P; Babuty D Ann Cardiol Angeiol (Paris); 2005 Jan; 54(1):38-43. PubMed ID: 15702910 [TBL] [Abstract][Full Text] [Related]
13. Management of recalled pacemakers and implantable cardioverter-defibrillators: a decision analysis model. Amin MS; Matchar DB; Wood MA; Ellenbogen KA JAMA; 2006 Jul; 296(4):412-20. PubMed ID: 16868299 [TBL] [Abstract][Full Text] [Related]
14. Multicenter experience with failed and recalled implantable cardioverter-defibrillator pulse generators. Hauser RG; Hayes DL; Epstein AE; Cannom DS; Vlay SC; Song SL; Tyers GF Heart Rhythm; 2006 Jun; 3(6):640-4. PubMed ID: 16731462 [TBL] [Abstract][Full Text] [Related]
15. Failure rates of leads, pulse generators, and programmers have not diminished over the last 20 years: formal monitoring of performance is still needed. BILITCH Registry and STIMAREC. Kawanishi DT; Song S; Furman S; Parsonnet V; Pioger G; Petitot JC; Godin JF Pacing Clin Electrophysiol; 1996 Nov; 19(11 Pt 2):1819-23. PubMed ID: 8945048 [TBL] [Abstract][Full Text] [Related]
16. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry. Gadler F; Valzania C; Linde C Europace; 2015 Jan; 17(1):69-77. PubMed ID: 25336667 [TBL] [Abstract][Full Text] [Related]
17. The effect of device advisories on implantable cardioverter-defibrillator therapy. Amin MS; Ellenbogen KA Curr Cardiol Rep; 2010 Sep; 12(5):361-6. PubMed ID: 20512632 [TBL] [Abstract][Full Text] [Related]
18. Risk of device malfunction in cancer patients with implantable cardiac device undergoing radiotherapy: a population-based cohort study. Zaremba T; Jakobsen AR; Søgaard M; Thøgersen AM; Johansen MB; Madsen LB; Riahi S Pacing Clin Electrophysiol; 2015 Mar; 38(3):343-56. PubMed ID: 25601489 [TBL] [Abstract][Full Text] [Related]
19. Impact of implantable cardioverter-defibrillator recalls on patients' anxiety, depression, and quality of life. Undavia M; Goldstein NE; Cohen P; Sinthawanarong K; Singson M; Bhutani D; Munson T; Gomes JA; Fischer A; Mehta D Pacing Clin Electrophysiol; 2008 Nov; 31(11):1411-8. PubMed ID: 18950298 [TBL] [Abstract][Full Text] [Related]
20. Complications associated with generator replacement in response to device advisories. Costea A; Rardon DP; Padanilam BJ; Fogel RI; Prystowsky EN J Cardiovasc Electrophysiol; 2008 Mar; 19(3):266-9. PubMed ID: 18081773 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]